Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Administrative Units/行政單位
  3. School History Room/校史室
  4. 校院出版品
  5. 中山醫學雜誌
  6. Idiopathic hyperammonemic encephalopathy after chemotherapy in a patient with rectal cancer
 
  • Details
Options

Idiopathic hyperammonemic encephalopathy after chemotherapy in a patient with rectal cancer

Journal Volume
中山醫學雜誌
Journal Issue
32卷1期
Pages
P101 - 103
Date Issued
2021-09-13T02:34:01Z
URI
https://scholars.csmu.edu.tw/handle/123456789/8661
Abstract
Idiopathic hyperammonemic encephalopathy is a rare complication of chemotherapy that has been described in patients with hematological malignancy, colon cancer, and hepatocellular carcinoma in the presence of noncirrhotic liver. The cause of this syndrome, which can be fatal, is not well understood. We present a case of rectal cancer without underlying liver dysfunction who suffered abrupt alteration in mental status after the first course of chemotherapy. Ammonia-lowering therapy was started immediately, without cessation of chemotherapy. For additional courses of chemotherapy, reduction to 75% of normal dosage was found to be safe and to produce satisfactory results.
Type
article
File(s)
Loading...
Thumbnail Image
Name

Idiopathic hyperammonemic encephalopathy after chemotherapy in a patient with rectal cancer.pdf

Size

333.31 KB

Format

Adobe PDF

Checksum

(MD5):b00bb3e0ad9753f1db51a072701c9aa4

Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback